Preclinical animal research on therapy dosimetry with dual isotopes

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue SUPPL. 1, 2011, Pages

  Konijnenberg, Mark W ^a   De Jong, Marion ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Dose effect models; Radiation dosimetry; Radionuclide therapy

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; AMBA LU 177; INDIUM 111; LUTETIUM 177; OCTREOTIDE; OCTREOTIDE[3 TYROSINE]; RADIOISOTOPE; UNCLASSIFIED DRUG; YTTRIUM 90;

ACCURACY; CANCER CONTROL; CANCER RADIOTHERAPY; CELL DENSITY; CLONOGENESIS; DOSE RESPONSE; DOSIMETRY; DRUG CLEARANCE; DRUG HALF LIFE; ELECTRON; EXPERIMENTAL ANIMAL; GAMMA RADIATION; KINETICS; LINEAR QUADRATIC MODEL; MATHEMATICAL MODEL; NEUROENDOCRINE TUMOR; NONHUMAN; PROSTATE CANCER; RADIATION DOSE; RADIOBIOLOGY; RADIOSENSITIVITY; REVIEW; TUMOR MODEL; TUMOR VOLUME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG EVALUATION, PRECLINICAL; INDIUM RADIOISOTOPES; LUTETIUM; NEOPLASMS; RADIATION DOSAGE; RADIOISOTOPES; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RATS; YTTRIUM RADIOISOTOPES;

EID: 79957954041     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1774-4     Document Type: Review

References (30)

1. MA Keenan MG Stabin WP Segars MJ Fernald 2010 RADAR realistic animal model series for dose assessment J Nucl Med 51 471 476 20197451 10.2967/jnumed.109.070532
2. KS Kolbert T Watson C Matei S Xu JA Koutcher G Sgouros, et al. 2003 Factors for liver, spleen and kidney J Nucl Med 44 784 791 12732681 1:CAS:528:DC%2BD3sXkt1Kisb8%3D
3. A Bitar A Lisbona P Thedrez C Sai Maurel D Le Forestier J Barbet, et al. 2007 Voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP) Phys Med Biol 52 1013 1025 17264367 10.1088/0031-9155/52/4/ 010 1:STN:280:DC%2BD2s%2FlvFOmsQ%3D%3D (Pubitemid 46646414)
4. TE Hui DR Fisher JA Kuhn LE Williams C Nourigat CC Badger, et al. 1994 A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates Cancer 73 3 Suppl 951 957 8306284 1:STN:280: DyaK2c7jvVykug%3D%3D (Pubitemid 24046655)
5. M de Jong WA Breeman BF Bernard A van Gameren E de Bruin WH Bakker, et al. 1999 Tumour uptake of the radiolabelled somatostatin analogue [DOTA0,TYR3]octreotide is dependent on the peptide amount Eur J Nucl Med 26 693 698 10398816 10.1007/s002590050439 (Pubitemid 29338656)
6. TM Behr RD Blumenthal S Memtsoudis RM Sharkey S Gratz W Becker, et al. 2000 Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments Clin Cancer Res 6 4900 4907 11156250 1:CAS:528:DC%2BD3MXotlekuw%3D%3D (Pubitemid 32110435)
7. M de Jong WA Breeman BF Bernard WH Bakker TJ Visser PP Kooij, et al. 2001 Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size J Nucl Med 42 1841 1846 11752083 (Pubitemid 34016355)
8. M de Jong WA Breeman BF Bernard WH Bakker M Schaar A van Gameren, et al. 2001 [177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy Int J Cancer 92 628 633 11340564 10.1002/1097- 0215(20010601)92:5<628::AID-IJC1244>3.0.CO;2-L (Pubitemid 32385702)
9. A Capello E Krenning B Bernard JC Reubi W Breeman M de Jong 2005 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy Eur J Nucl Med Mol Imaging 32 1288 1295 16021448 10.1007/s00259-005-1877-x 1:CAS:528:DC%2BD2MXht1Skt73I (Pubitemid 41598720)
10. C Müller R Schibli EP Krenning M de Jong 2008 Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer J Nucl Med 49 623 629 18344429 10.2967/jnumed.107.047704 (Pubitemid 351520611)
11. M Melis E Vegt MW Konijnenberg M de Visser M Bijster M Vermeij, et al. 2010 Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides J Nucl Med 51 973 977 20484435 10.2967/jnumed.109.074310 1:CAS:528: DC%2BC3cXosl2ksbg%3D
12. M Melis F Forrer A Capello M Bijster BF Bernard JC Reubi, et al. 2007 Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy Q J Nucl Med Mol Imaging 51 324 333 17923824 1:STN:280:DC%2BD2sngtFSlug%3D%3D (Pubitemid 350267703)
13. S Pauwels R Barone S Walrand F Borson-Chazot R Valkema LK Kvols, et al. 2005 Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs J Nucl Med 46 Suppl 1 92S 98S 15653657 1:CAS:528:DC%2BD2MXhsVeksLY%3D (Pubitemid 47619024)
14. R Suwinski JM Taylor HR Withers 1999 The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect Radiother Oncol 50 57 66 10225558 10.1016/S0167-8140(99)00014-6 1:STN:280:DyaK1M3ktVSrug%3D%3D (Pubitemid 29136739)
15. HB Marcos SK Libutti HR Alexander IA Lubensky DL Bartlett MM Walther, et al. 2002 Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison Radiology 225 751 758 12461257 10.1148/radiol.2253011297 (Pubitemid 35387113)
16. JA O'Donoghue M Bardiès TE Wheldon 1995 Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides J Nucl Med 36 1902 1909 7562062
17. AE Nahum 1996 Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters Phys Med Biol 41 1957 1972 8912374 10.1088/0031-9155/41/10/008 1:CAS:528:DyaK28XmsVOitL4%3D (Pubitemid 26333634)
18. TC Stephens JH Peacock WU Shipley GG Steel 1984 Response to continuous irradiation (CI) in relation to the initial slope of the cell survival curve for tumours and bone marrow Br J Cancer 49 Suppl VI 271 274 (Pubitemid 14132006)
19. S Verwijnen A Capello B Bernard G van den Aardweg M Konijnenberg W Breeman, et al. 2004 Low-dose-rate irradiation by 131I versus high-dose-rate external-beam irradiation in the rat pancreatic tumor cell line CA20948 Cancer Biother Radiopharm 19 285 292 15285875 10.1089/1084978041425098 1:CAS:528:DC%2BD2cXlslCnt7w%3D (Pubitemid 38924493)
20. GR Borst M Ishikawa J Nijkamp M Hauptmann H Shirato G Bengua, et al. 2010 Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters Int J Radiat Oncol Biol Phys 77 1596 1603 20231066 10.1016/j.ijrobp.2009.10.015
21. JF Fowler 2008 Linear quadratics is alive and well Int J Radiat Oncol Biol Phys 72 957 959 19014784 10.1016/j.ijrobp.2008.06.1929
22. JZ Wang M Guerrero XA Li 2003 How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55 194 203 12504054 10.1016/S0360-3016(02)03828-2 (Pubitemid 36020360)
23. JZ Wang XA Li 2005 Impact of tumor repopulation on radiotherapy planning Int J Radiat Oncol Biol Phys 61 220 227 15629615 10.1016/j.ijrobp.2004.09.043 (Pubitemid 40039126)
24. S Levegrün A Jackson MJ Zelefsky MW Skwarchuk ES Venkatraman W Schlegel, et al. 2001 Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data Int J Radiat Oncol Biol Phys 51 1064 1080 11704332 10.1016/S0360-3016(01)01731-X (Pubitemid 33026439)
25. CC Ling LE Gerweck M Zaider E Yorke 2010 Dose-rate effects in external beam radiotherapy redux Radiother Oncol 95 261 268 20363041 10.1016/j.radonc. 2010.03.014
26. LE Lantry E Cappelletti ME Maddalena JS Fox W Feng J Chen, et al. 2006 177Lu-AMBA: synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer J Nucl Med 47 1144 1152 16818949 1:CAS:528:DC%2BD28XnslSmtrc%3D (Pubitemid 47558898)
27. JA O'Donoghue 1999 Implications of nonuniform tumor doses for radioimmunotherapy J Nucl Med 40 1337 1341 10450686 (Pubitemid 29385643)
28. S Webb AE Nahum 1993 A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic density Phys Med Biol 38 653 666 8346278 10.1088/0031-9155/38/6/001 1:STN:280:DyaK3szkvVejsQ%3D%3D (Pubitemid 23188329)
29. E Malinen S Freykowski J Kummermehr 2000 Regrowth delay analysis of irradiated tumors in the curative dose region Int J Radiat Oncol Biol Phys 46 173 177 10656390 10.1016/S0360-3016(99)00423-X 1:STN:280:DC%2BD3c7itVWrsQ%3D%3D (Pubitemid 30021497)
30. FM Buffa AE Nahum 2000 Monte Carlo dose calculations and radiobiological modeling: analysis of the effect of the statistical noise of the dose distribution on the probability of tumour control Phys Med Biol 45 3009 3023 11049185 10.1088/0031-9155/45/10/318 1:STN:280:DC%2BD3crgtFOmsQ%3D%3D